Skip to content
MedsAcross

Medicine

Morphine 2 mg/1 mL injection

Morphine · Intravenous
Available on requestPrescription onlyUS FDAControlled, schedule CIIGeneric name

Morphine 2 mg/1 mL injection is a generic prescription medicine for intravenous use, made by 2 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.

Availability

Available on request

Export supply from India to licensed buyers

Typical lead time

On request

Counted from payment and complete documents

Shipping

Ambient

DO NOT FREEZE. Store at 20°C to 25°C (68°F to 77°F) until ready to use…

Key facts

Active ingredient (INN)
Morphine
Brand
Sold under the generic name
Strength
2 mg/1 mL
Dosage form
Injection
Route
Intravenous
Packs
10 syringes of 1 mL, 10 cartridges of 1 mL
Manufacturers
HospiraHikma Pharmaceuticals
Origin register
US FDA, United States
Storage
DO NOT FREEZE. Store at 20°C to 25°C (68°F to 77°F) until ready to use. PROTECT FROM LIGHT.
Cold chain
Not required on record
Prescription status
Prescription only
Controlled substance
Schedule CII
ATC code
N02AA01 Morphine
HS code (indicative)
3004.90Indicative only. Your customs broker confirms the final tariff code.
Marketing category
marketed
Marketed since
23 August 2012
Identifiers
RxCUI 998212, 998213, 1729197 +1DailyMed set ID 69a0d5be-3211-4b7f-962b-e9d9a507321f, be420e8b-bcb0-49b5-bb4d-1df8b9959809NDC 0641-6191, 0409-1890Application ANDA211452, NDA202515

Record updated 12 November 2026

Documents available

Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.

No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.

Packs

Packs from every labeler of this generic presentation.

PackCodeLabelerMarketed since
10 syringe in 1 package / 1 mL in 1 syringe0641-6191-10Hikma Pharmaceuticals18 April 2025
10 cartridge in 1 carton / 1 mL in 1 cartridge0409-1890-01Hospira23 August 2012
10 syringe in 1 cello pack / 1 mL in 1 syringe0409-1890-23Hospira11 January 2021
25 vial, single-dose in 1 box / 1 mL in 1 vial, single-dose63323-452-01—10 April 2018
10 syringe, glass in 1 carton / 1 mL in 1 syringe, glass76045-004-11—25 November 2019

Status by register

Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.

RegisterStatusSource
US FDAListed, marketedSource record for this pageChecked 12 November 2026
US FDAFirst approved 18 September 1984Drugs@FDA
EU (EMA)Not recorded—
India (CDSCO)Not yet confirmed against CDSCO approval lists—
United StatesRegisteredUS FDA (NDC directory, openFDA)Checked 12 November 2026

Import route

Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.

Import guides are available for 25 countries. Pick one to see its route summary.

BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides

Alternatives

Other makers and brands of Morphine 2 mg/1 mL injection.

Compare 1

Other strengths and forms of Morphine

Clinical summary

Morphine is an opioid agonist indicated only for intrathecal or epidural infusion in the management of intractable chronic pain severe enough to require an opioid analgesic and for which less invasive means of controlling pain are inadequate. MedsAcross supplies Morphine for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.

Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review

Read about Morphine

For healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.

Data sources

Need Morphine 2 mg/1 mL injection for your hospital or patient?

Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.